Maria Jancevski, MD | |
800 S Adams Rd, Suite 201, Birmingham, MI 48009-7005 | |
(248) 644-8060 | |
(248) 644-5081 |
Full Name | Maria Jancevski |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 20 Years |
Location | 800 S Adams Rd, Birmingham, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467661918 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 4301084206 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oakland Ophthalmic Surgery Pc | 6103829940 | 5 |
Beaumont Medical Group- Specialty Services | 7214299866 | 787 |
News Archive
Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announces the establishment of Eisai Limited in Canada, the world's ninth largest pharmaceutical market. As a wholly-owned subsidiary of Eisai Inc., Eisai Limited will be based in Mississauga, Ontario, one of the largest biopharmaceutical clusters and medical communities in North America.
A new study helps explain how parts of the brain maintain their delicate balance of zinc, an element required in minute but crucial doses, particularly during embryonic development.
For less active adults, the amount of time spent sitting may be associated with an increased risk of death; however, increasing physical activity to recommended levels may eliminate this association in some, according to a study published today in the annual cardiovascular health promotion issue of the Journal of the American College of Cardiology.
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.
› Verified 9 days ago
Entity Name | Oakland Ophthalmic Surgery Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801880984 PECOS PAC ID: 6103829940 Enrollment ID: O20060816000207 |
News Archive
Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announces the establishment of Eisai Limited in Canada, the world's ninth largest pharmaceutical market. As a wholly-owned subsidiary of Eisai Inc., Eisai Limited will be based in Mississauga, Ontario, one of the largest biopharmaceutical clusters and medical communities in North America.
A new study helps explain how parts of the brain maintain their delicate balance of zinc, an element required in minute but crucial doses, particularly during embryonic development.
For less active adults, the amount of time spent sitting may be associated with an increased risk of death; however, increasing physical activity to recommended levels may eliminate this association in some, according to a study published today in the annual cardiovascular health promotion issue of the Journal of the American College of Cardiology.
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.
› Verified 9 days ago
Entity Name | Beaumont Medical Group- Specialty Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announces the establishment of Eisai Limited in Canada, the world's ninth largest pharmaceutical market. As a wholly-owned subsidiary of Eisai Inc., Eisai Limited will be based in Mississauga, Ontario, one of the largest biopharmaceutical clusters and medical communities in North America.
A new study helps explain how parts of the brain maintain their delicate balance of zinc, an element required in minute but crucial doses, particularly during embryonic development.
For less active adults, the amount of time spent sitting may be associated with an increased risk of death; however, increasing physical activity to recommended levels may eliminate this association in some, according to a study published today in the annual cardiovascular health promotion issue of the Journal of the American College of Cardiology.
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Maria Jancevski, MD 800 S Adams Rd, Suite 201, Birmingham, MI 48009-7005 Ph: () - | Maria Jancevski, MD 800 S Adams Rd, Suite 201, Birmingham, MI 48009-7005 Ph: (248) 644-8060 |
News Archive
Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announces the establishment of Eisai Limited in Canada, the world's ninth largest pharmaceutical market. As a wholly-owned subsidiary of Eisai Inc., Eisai Limited will be based in Mississauga, Ontario, one of the largest biopharmaceutical clusters and medical communities in North America.
A new study helps explain how parts of the brain maintain their delicate balance of zinc, an element required in minute but crucial doses, particularly during embryonic development.
For less active adults, the amount of time spent sitting may be associated with an increased risk of death; however, increasing physical activity to recommended levels may eliminate this association in some, according to a study published today in the annual cardiovascular health promotion issue of the Journal of the American College of Cardiology.
An active ingredient in eye drops that were being developed for the treatment of a form of eye disease has shown promise for treating an aggressive form of blood cancer. Scientists at the Wellcome Sanger Institute, University of Cambridge, University of Nottingham and their collaborators have found that this compound, which targets an essential cancer gene, could kill leukemia cells without harming non-leukemic blood cells.
› Verified 9 days ago
Dr. Carl F Clavenna, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 S Adams Rd, Ste 200, Birmingham, MI 48009 Phone: 248-646-3733 Fax: 248-642-2566 | |
Robert L. Stephenson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 800 S Adams Rd, Suite 201, Birmingham, MI 48009 Phone: 248-644-8060 Fax: 248-644-5081 | |
Timothy P Page, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 800 S Adams Rd, Suite 201, Birmingham, MI 48009 Phone: 248-644-8060 Fax: 248-644-5081 | |
Robert C. Erickson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 800 S Adams Rd, Suite 201, Birmingham, MI 48009 Phone: 248-644-8060 Fax: 248-644-5081 | |
Jacob Diskin, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 600 S Adams Rd Ste 200, Birmingham, MI 48009 Phone: 248-646-3733 Fax: 248-642-2566 | |
Gregory Bernard Fitzgerald, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 S Adams Rd, Ste 200, Birmingham, MI 48009 Phone: 248-646-3733 Fax: 248-642-2566 |